My interpretation of the official (USP, FDA, ICH) system suitability "suggestions" is that they are minimal. I see nothing in the documents that precludes adding other criteria as necessary to ensure that the system is suitable for the analysis. It is up to the developer to specify (and justify) those criteria.
Some possibilities:
- retention time (or, for isocratic separations, k') windows for key peaks
- resolution between key pairs of peaks
- tailing/fronting
- detector baseline noise (for trace analysis, this is the major determinant of LOD & LLOQ)
- plate number (if you have specified retention and resolution, then plate number is redundant; I usually throw in a value just to keep the auditors happy)
- system pressure (this can provide early warning of impending column problems)
- repeatability of replicate injections
- linearity of the calibration curve over an appropriate range (you can get into whole discussions about which statistical measures to apply here

)
I'm sure people can suggest more.